Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
Endothelial dysfunction is an early sign of diabetic cardiovascular disease and may contribute to progressive diabetic nephropathy (DN). There is increasing evidence that dysfunction of the endothelial tight junction is a crucial step in the development of endothelial hyperpermeability, but it is un...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3828237?pdf=render |
_version_ | 1818922454255403008 |
---|---|
author | Hui Peng Pengli Luo Yuanqing Li Cheng Wang Xun Liu Zengchun Ye Canming Li Tanqi Lou |
author_facet | Hui Peng Pengli Luo Yuanqing Li Cheng Wang Xun Liu Zengchun Ye Canming Li Tanqi Lou |
author_sort | Hui Peng |
collection | DOAJ |
description | Endothelial dysfunction is an early sign of diabetic cardiovascular disease and may contribute to progressive diabetic nephropathy (DN). There is increasing evidence that dysfunction of the endothelial tight junction is a crucial step in the development of endothelial hyperpermeability, but it is unknown whether this occurs in glomerular endothelial cells (GEnCs) during the progression of DN. We examined tight junction dysfunction of GEnCs during early-stage DN and the potential underlying mechanisms. We also examined the effect of simvastatin (3-Hydroxy-3-methylglutaryl CoA reductase inhibitor) on dysfunction of the tight junctions of cultured GEnCs and in db/db mice with early-stage DN.We assessed the expression of occludin and ZO-1, two major components of the tight junction complex, in cultured rat GEnCs treated with high glucose and in 12 week-old db/db mice with early-stage DN. We also investigated activation of RhoA/ROCK1 signaling, GEnC permeability, and renal function of the mice.High glucose suppresses occludin expression and disrupts occludin/ZO-1 translocation in GEnCs. These changes were associated with increased permeability to albumin and activation of RhoA/ROCK1 signaling. Occludin and ZO-1 dysregulation also occurred in the glomeruli of mice with early-stage DN, and these abnormalities were accompanied by albuminuria and activation of RhoA/ROCK1 in isolated glomeruli. Simvastatin prevented high glucose or hyperglycemia-induced dysregulation of occludin and ZO-1 by inhibition of RhoA/ROCK1 signaling in cultured GEnCs and in db/db mice with early-stage DN.Our results indicate that activation of RhoA/ROCK1 by high glucose disrupts the expression and translocation of occludin/ZO-1 and that simvastatin alleviates occludin/ZO-1 dysregulation and albuminuria by suppressing RhoA/ROCK1 signaling during early-stage DN. These results suggest a potential therapeutic strategy for preventing the onset of albuminuria in early-stage DN. |
first_indexed | 2024-12-20T01:53:48Z |
format | Article |
id | doaj.art-d971b41463314771a8df5b4998d1cec4 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-20T01:53:48Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-d971b41463314771a8df5b4998d1cec42022-12-21T19:57:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e8000910.1371/journal.pone.0080009Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.Hui PengPengli LuoYuanqing LiCheng WangXun LiuZengchun YeCanming LiTanqi LouEndothelial dysfunction is an early sign of diabetic cardiovascular disease and may contribute to progressive diabetic nephropathy (DN). There is increasing evidence that dysfunction of the endothelial tight junction is a crucial step in the development of endothelial hyperpermeability, but it is unknown whether this occurs in glomerular endothelial cells (GEnCs) during the progression of DN. We examined tight junction dysfunction of GEnCs during early-stage DN and the potential underlying mechanisms. We also examined the effect of simvastatin (3-Hydroxy-3-methylglutaryl CoA reductase inhibitor) on dysfunction of the tight junctions of cultured GEnCs and in db/db mice with early-stage DN.We assessed the expression of occludin and ZO-1, two major components of the tight junction complex, in cultured rat GEnCs treated with high glucose and in 12 week-old db/db mice with early-stage DN. We also investigated activation of RhoA/ROCK1 signaling, GEnC permeability, and renal function of the mice.High glucose suppresses occludin expression and disrupts occludin/ZO-1 translocation in GEnCs. These changes were associated with increased permeability to albumin and activation of RhoA/ROCK1 signaling. Occludin and ZO-1 dysregulation also occurred in the glomeruli of mice with early-stage DN, and these abnormalities were accompanied by albuminuria and activation of RhoA/ROCK1 in isolated glomeruli. Simvastatin prevented high glucose or hyperglycemia-induced dysregulation of occludin and ZO-1 by inhibition of RhoA/ROCK1 signaling in cultured GEnCs and in db/db mice with early-stage DN.Our results indicate that activation of RhoA/ROCK1 by high glucose disrupts the expression and translocation of occludin/ZO-1 and that simvastatin alleviates occludin/ZO-1 dysregulation and albuminuria by suppressing RhoA/ROCK1 signaling during early-stage DN. These results suggest a potential therapeutic strategy for preventing the onset of albuminuria in early-stage DN.http://europepmc.org/articles/PMC3828237?pdf=render |
spellingShingle | Hui Peng Pengli Luo Yuanqing Li Cheng Wang Xun Liu Zengchun Ye Canming Li Tanqi Lou Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. PLoS ONE |
title | Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. |
title_full | Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. |
title_fullStr | Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. |
title_full_unstemmed | Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. |
title_short | Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. |
title_sort | simvastatin alleviates hyperpermeability of glomerular endothelial cells in early stage diabetic nephropathy by inhibition of rhoa rock1 |
url | http://europepmc.org/articles/PMC3828237?pdf=render |
work_keys_str_mv | AT huipeng simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 AT pengliluo simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 AT yuanqingli simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 AT chengwang simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 AT xunliu simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 AT zengchunye simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 AT canmingli simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 AT tanqilou simvastatinalleviateshyperpermeabilityofglomerularendothelialcellsinearlystagediabeticnephropathybyinhibitionofrhoarock1 |